Mogamulizumab (KW-0761) is a recombinant monoclonal antibody that targets CC chemokine receptor 4 (CCR4). This antibody facilitates the elimination of tumor cells through antibody-dependent cellular cytotoxicity (ADCC), a critical mechanism for immune-mediated tumor cell eradication. Mogamulizumab is primarily utilized in the investigation of various cancers, including adult T-cell leukemia/lymphoma (ATLL) and cutaneous T-cell lymphoma (CTCL), providing a valuable tool for research in oncology and immunotherapy.
Mogamulizumab (KW-0761) is a recombinant monoclonal antibody that targets CC chemokine receptor 4 (CCR4). This antibody facilitates the elimination of tumor cells through antibody-dependent cellular cytotoxicity (ADCC), a critical mechanism for immune-mediated tumor cell eradication. Mogamulizumab is primarily utilized in the investigation of various cancers, including adult T-cell leukemia/lymphoma (ATLL) and cutaneous T-cell lymphoma (CTCL), providing a valuable tool for research in oncology and immunotherapy.
This calculator helps you calculate mass of compound based on solution concentration, volume and molecular weight in a specific solution using the formula:
